Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.

Keita M, Seck M, Diallo AB, Touré SA, Bousso ES, Gueye SM, Dieng N, Dieng F, Faye BF, Diop S

Open source

DOI
10.1080/03630269.2024.2378069
Published
2024 Jul
Container
Hemoglobin
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/03630269.2024.2378069,
  title = {Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.},
  author = {Keita M and Seck M and Diallo AB and Touré SA and Bousso ES and Gueye SM and Dieng N and Dieng F and Faye BF and Diop S},
  year = {2024},
  journal = {Hemoglobin},
  doi = {10.1080/03630269.2024.2378069},
  url = {https://doi.org/10.1080/03630269.2024.2378069}
}

RIS

TY  - JOUR
TI  - Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.
AU  - Keita M
AU  - Seck M
AU  - Diallo AB
AU  - Touré SA
AU  - Bousso ES
AU  - Gueye SM
AU  - Dieng N
AU  - Dieng F
AU  - Faye BF
AU  - Diop S
PY  - 2024
JO  - Hemoglobin
DO  - 10.1080/03630269.2024.2378069
UR  - https://doi.org/10.1080/03630269.2024.2378069
ER  - 

APA

M, K., M, S., AB, D., SA, T., ES, B., SM, G., N, D., F, D., BF, F., & S, D. (2024). Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.. Hemoglobin. https://doi.org/10.1080/03630269.2024.2378069

Source records